Using Travelan to Boost Immune Response in Vitro to COVID-19
Clinical trial NCT04643561 · UNKNOWN
Trial details
- NCT number
- NCT04643561
- Sponsor
- Hadassah Medical Organization
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2020-12-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.